Genofax, a healthcare tech startup, has introduced a new form of technology called AI-enabled Health-Metric Determination (AIeh-MD) that, by monitoring an individual's gut microbiome, can predict metabolic trends and potentially identify early signs of conditions like obesity, diabetes, inflammatory bowel disease, etc. The company was founded by two Bangladeshi scientists